Since both the cellular source of circulating TRAIL and the mechanisms regulating TRAIL secretion are not completely understood, it remains unclear whether the observed positive correlation of TRAIL levels with obesity reflects an enhanced production from adipocytes or the consequence of other biological pathways activated in obesity and hyperlipidemia. The gene discussed is TNFSF10; the disease is obesity due to melanocortin 4 receptor deficiency.